Strong TripleTOF 5600 Sales Drive Double-Digit Q3 Revenue Growth at AB Sciex
October 21, 2011
Strong TripleTOF 5600 Sales Drive Double-Digit Q3 Revenue Growth at AB Sciex
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- AB Sciex Posts Strong Q4 Sales as Academic, Research Markets Grow at Double-Digit Rates
February 3, 2012 / ProteoMonitor - Strong TripleTOF 5600 Sales Drive Mid-Teens Q2 Growth at AB Sciex
July 22, 2011 / ProteoMonitor - At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases
January 11, 2013 / ProteoMonitor - At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor - Strong Demand for Triple-TOF 5600 Drives AB Sciex's Q1 Revenue Growth
April 22, 2011 / ProteoMonitor